COVID-19 vaccine and blood cancer - Takeaways - MDSpire

COVID-19 vaccine and blood cancer

Dr. Nikhil Munshi and colleagues reported a study demonstrating that COVID-19 vaccination offers less protection for multiple myeloma patients, reinforcing the need for these patients to use additional precautions.

  • December 22, 2021

Share

  • 1

    COVID-19 vaccination provides reduced protection for multiple myeloma patients compared to the general population.

  • 2

    Patients with myeloma should take additional precautions, including social distancing and mask-wearing, even if vaccinated.

  • 3

    The effectiveness of the vaccine diminishes over time, particularly around six months post-vaccination.

  • 4

    Myeloma patients who have recently undergone chemotherapy show lower vaccine effectiveness than those who have not.

  • 5

    Booster vaccinations are recommended for myeloma patients to enhance their protection against COVID-19.

Original Source(s)

COVID-19 vaccine and blood cancer

  • December 22, 2021

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report

Management of toxicities from antibody – drug conjugates in breast cancer